Acquisition Opportunity Cure Medical was acquired by ConvaTec in March 2021, suggesting potential channel integration opportunities, distribution synergies, and cross-sell possibilities within ConvaTec’s existing medical products and continence care portfolio.

Product Portfolio Expansion Strong focus on a broad range of intermittent catheters including closed systems and hydrophilic options signals upsell potential to customers seeking comprehensive solution sets across genders and pediatric use.

Targeted Markets Limited internal headcount (2-10 employees) points to reliance on partners and networks; explore partnerships with larger distributors and healthcare systems to scale reach for Cure Medical products.

Growth Levers Recent product launches such as Cure Dextra Closed System and expanded hydrophilic lines indicate readiness for rapid adoption; leverage clinical education and trial programs to accelerate adoption in new markets.

Strategic Partnerships Past collaborations like The Rollettes Experience and a focus on patient-centered benefits present opportunities for co-branding, advocacy programs, and targeted outreach to disability and caregiver communities.